Introduction
============

Implementation research is the scientific study of methods to promote the rapid uptake of research findings and, hence, improve the health of individuals and populations \[[@B1]\]. Group-randomized trials (GRTs) are an increasingly important tool for implementation research. Typically, individuals (*e.g*., clinicians) are clustered within subunits (*e.g*., clinics) that may be further clustered within higher-level units (*e.g*., facilities or health systems). Accordingly, the unit of randomization and the intervention target may be different (*e.g*., clinics and clinicians, respectively). Unlike the traditional randomized clinical trial (RCT), which focuses on efficacy, implementation research focuses on effectiveness \[[@B2],[@B3]\]. The goal is to understand how efficacious interventions delivered in relatively homogenous populations can be deployed within the community to benefit the population at large. Thus, external validity (generalizability) of GRTs depends on the extent that participants at different levels of clustering represent the population of interest.

Recruitment is important for traditional RCTs, primarily to achieve the needed power to detect significant differences in outcomes; for GRTs, recruitment is important to ensure power and generalizablity. The Myocardial Infarction Plus Comorbidities (MI-Plus) study was a nationwide GRT of Veterans Health Administration (VHA) primary care clinicians who cared for ambulatory post-myocardial infarction (MI) patients, many of whom had multiple comorbidities. The 27-month clinician-directed, Internet-delivered intervention consisted of quarterly case-based interactive educational modules, one to three reviews per month of recently published studies of high clinical impact and relevance to the quality indicators, summaries and links to guidelines applicable to the care of post-MI patients, and downloadable practice tools and patient educational materials \[[@B4]\]. The website was developed using service-oriented architecture and design principles refined in prior studies \[[@B5],[@B6]\]. Iterative usability sessions were used to refine the content. Clinicians in control clinics were provided a link to an existing VHA Office of Quality and Performance website that contained links to a wide range of clinical guidelines for various medical conditions (<http://www.healthquality.va.gov/>).

Similar to other multicenter implementation studies, the clinic was the unit of randomization \[[@B7]\]. Performance improvement was calculated as the change (pre-intervention period vs. postintervention period) in the proportion of patients receiving each clinical indicator within the clinic \[[@B8]\]. Individual clinicians were embedded within community-based outpatient clinics (clinics), which were embedded organizationally, though not necessarily colocated, within VHA parent facilities (medical centers). This design necessitated several sequential and, at times, simultaneous recruitment efforts targeting individual clinicians, clinics, and facilities. This report describes those recruitment activities as well as the recruitment times and participation rates at the facility, clinic, and clinician level.

Methods
=======

The VHA is the largest integrated healthcare system in the United States, with 153 medical centers and over 900 ambulatory care and community-based outpatient clinics providing care to an estimated 5.5 million individuals in 2008 \[[@B9]\]. Each facility typically consists of an acute care component, on-site outpatient clinics physically located at the facility, and off-site outpatient clinics distributed across the region served by the facility. Many facilities are also affiliated with an academic medical center and support research activities. Research within the facility must be formally approved by the facility\'s Institutional Review Board (IRB) and its Research and Development (R&D) committee. Any research conducted at a clinic is governed by the policies of its parent facility.

The study was funded through the VHA Health Services Research and Development (HSR&D) office \[IHD 04-387\] and by a parallel National Institutes of Health study \[R01 HL70786-02\]\[[@B10],[@B11]\]. We conducted formative work with a panel of expert physicians using nominal group techniques to choose from among 36 potential quality indicators for complex ambulatory post-MI patients that would be both most feasible and most valid \[[@B8]\]. We also conducted focus groups and case-vignette surveys of clinicians, including VHA clinicians, to develop the intervention. The Birmingham VA Medical Center, Birmingham, AL, served as the study\'s coordinating center. After approval from its IRB and R&D committees, the Birmingham facility and its six affiliated outpatient clinics were the first study enrollees in November 2003.

A priori, we planned a sample size of 200 clinics to provide \> 80% statistical power to detect a 5% difference in improvement between intervention and control clinics for all of the primary clinical indicators over a range of assumptions. Our initial recruitment plan allotted six months to recruit the 200 clinics using a strategic approach of recruiting parent facilities using high-yield targets (*i.e*., personal contacts) and leveraging regional leadership support for our study. As only one-third of the requisite clinics were recruited after eight months, we re-evaluated the initial recruitment procedures (phase 1) and revised them to improve recruitment in phase 2.

Phase 1 facility recruitment protocol
-------------------------------------

In the first phase of recruitment (April 2004-November 2004), potential facilities for recruitment were identified using the 2003 VA Station Tracking (VAST) database. To be eligible, facilities had to have an affiliated IRB; four or more eligible clinics; and no ongoing, potentially overlapping, quality-improvement project. The four-clinic requirement was relaxed towards the end of recruitment. Clinics were eligible if they were noncontract (owned and operated by VHA), delivered primary care, used the VHA\'s electronic health record (EHR) system, and provided Internet access to all clinicians. For eligible facilities, we sought a physician willing to serve as a local principal investigator (PI). To identify funded investigators and other potential contacts within each facility who could serve as a local PI, the VHA R&D and HSR&D websites were reviewed. The subsequent list was reviewed by our study investigators to identify high-yield targets (*i.e*., personal contacts) to initiate facility recruitment. The project coordinator (a registered nurse) called and emailed these high-yield targets on behalf of the study investigators.

Phase 2 facility recruitment protocol
-------------------------------------

In the second phase of facility recruitment (December 2004-July 2005), \"cold\" contacts were recruited via emails and telephone by targeting facilities with the largest number of associated clinics. To increase recruitment and its efficiency, we developed and implemented a standardized recruitment protocol (Figure [1](#F1){ref-type="fig"}). During this second phase, we added two physician investigators to assume primary responsibility for recruitment of local PIs and leverage physician-to-physician communications \[[@B12]\]. To facilitate the IRB approval process at participating facilities, a research assistant was also hired to specifically oversee all IRB protocols and to prepare a standard IRB packet for each facility. In phase 1, research staff assisted each facility with IRB preparation but did not prepare a standard IRB packet. The 14 facilities for which a local PI could not be found or for which IRB approval was never obtained were classified as \"declined\" facilities (Figure [2](#F2){ref-type="fig"}).
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The physician investigators followed the recruitment protocol shown in Figure [1](#F1){ref-type="fig"}. Contact information (name, position, telephone number, and email) for potential physician PIs was obtained from the VAST database and facility websites. These initial emails contained recruitment materials (the study abstract, a press release, and a recruitment letter), outlined the need for a local PI, and described the general expectations of this position. During the telephone call, questions were answered, interest was ascertained, and if the individual declined to participate, they were asked to refer others who might be interested. This process was continued until a local PI was identified or all leads were exhausted, including contacting the chief of medicine, IRB chair, and chief of staff. To cover costs of participation, the facility received a site distribution of \$2,500.

Facilities were recruited until we achieved our goal of 200 eligible clinics. While facility recruitment continued in a rolling fashion, we simultaneously recruited clinics and clinicians of enrolled facilities to participate in the intervention study. Clinicians at each facility\'s associated clinics were not recruited or provided study materials until a local PI was identified, all IRB requirements were met, and a list of all eligible clinicians and their email addresses were obtained. The date these materials were approved and posted was the facility\'s launch date.

Clinic and clinician recruitment protocol
-----------------------------------------

A clinic was enrolled and randomized when the first eligible clinician (a physician, physician assistant, or nurse practitioner) at that clinic logged on to the study website. All clinicians at a clinic were randomized to the same arm, but only clinicians who logged on were enrolled. Clinicians were recruited continuously throughout the two-year intervention period. Immediately following the facility launch, clinicians were sent an email, a postal letter, and study flier that described the study and how to log on to the study webpage. Subsequent weekly email and fax reminders were sent to clinicians who had not yet logged on. Approximately four to six weeks after the facility launch date, one of the study physicians sent a more personalized email to each clinician at clinics not yet enrolled (this involved seven clinics over the course of the study). If unsuccessful, telephone contact was attempted with each clinician at clinics not yet enrolled. Telephone attempts were discontinued if a clinician was reached or three attempts were made. The date and type of contact attempt was tracked in an Excel (Microsoft Corporation, Redmond, WA, USA) spreadsheet; however, more recent contact attempts were overwritten on earlier attempts. The primary goal of these attempts was to increase clinic enrollment and not clinician enrollment (*i.e*., if any clinician at a given clinic logged on, the clinic was considered to be enrolled). Proactive emails were sent notifying all clinicians (enrolled or nonenrolled) of new updates and materials. Such reminders have been demonstrated to increase participation in Internet-delivered clinician interventions \[[@B13]\]. Lastly, a monthly recruitment report was emailed to the local PI at the associated parent facility. The report contained the name of each clinician and his/her enrollment status. Local PIs were encouraged to informally facilitate recruitment where feasible by encouraging their peers to log on. All enrolled intervention and control clinicians could obtain continuing education credits for reviewing eligible educational materials on the website. No other incentives were provided owing to VHA policy.

Statistical analysis
--------------------

Differences in facility participation rates were assessed according to the presence of a formally funded existing VHA HSR&D program at the time of recruitment (defined as a Center of Excellence, Research Enhancement Award Program, or a Targeted Research Enhancement Program), rural-urban locale,\[[@B14]\] geographic region of the United States, and facility size in terms of number of affiliated clinics. Differences in clinic participation rates among participating facilities were similarly assessed, with clinic size classified according to the number of affiliated clinicians. The analyses were repeated among participating facilities to assess differences by recruitment phase.

We defined four time intervals to represent the different aspects of the total recruitment time for a clinic: (1) initial facility contact to recruitment of a local PI, (2) recruitment of a local PI to approval by both the R&D committee and the IRB, (3) IRB or R&D approval (whichever the facility required last) to launch, and 4) launch to first clinic enrollment. Interval 2 represents an estimate of facility approval time. Because all time intervals were skewed, the median was used as a measure of central tendency. Kruskal-Wallis tests were used to assess differences of time variables across categorical variables, and Spearman rank correlations were used to measure associations of selected characteristics, specifically, measures of facility and clinic size, with time intervals.

Results
=======

Facility participation
----------------------

Of 118 facilities identified as potentially eligible (Figure [2](#F2){ref-type="fig"}), 66 were confirmed eligible. Of the 66, 12 had a formally established VA HSR&D program and 59 were in an urban area (Table [1](#T1){ref-type="table"}). The largest proportion (n = 23, 35%) was in the midwest and the lowest in the west (n = 12, 18%). The median number of affiliated clinics was five (interquartile range of four to six). Forty-eight facilities (73%) located across the continental United States (Figure [3](#F3){ref-type="fig"}) participated. Facility participation rates were higher among facilities with a formally established VA HSR&D program, those located in an urban area, those not in the west, and those that were smaller (Table [1](#T1){ref-type="table"}).

###### 

Distribution of eligible facilities according to participation: the VA MI-Plus study

                                                                   Participated                             
  ------------------------------------------------ ------- ------- -------------- --------- ------- ------- ---------
                                                   **N**   **%**   **N**          **%**     **N**   **%**   
  Had a VHA health services research program       12      18.2    12             25.0      0       0.0     .03
  Located in an urban area                         59      89.4    45             95.7      14      77.8    .045
  [Geographic region]{.ul}                                                                                  .03
  New England/Mid-Atlantic                         16      24.2    14             29.2      2       11.1    
  Midwest                                          23      34.8    16             33.3      7       38.9    
  South                                            15      22.7    13             27.1      2       11.1    
  West                                             12      18.2    5              10.4      7       38.9    
  [Number of affiliated outpatient clinics]{.ul}                                                            .07\*
  2-3                                              16      24.2    14             29.2      2       11.1    
  4-5                                              30      45.4    22             45.8      8       44.4    
  6-15                                             20      30.3    12             25.0      8       44.4    
  Median (interquartile range)                     4.5     (4-6)   4              (3-5.5)   5       (4-7)   .02\*\*

\**p*for trend test; \*\**p*for Wilcoxon rank sum test.

VHA = Veterans Health Administration.
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For the 18 facilities that did not participate, a willing PI could not be identified in 14 (Figure [2](#F2){ref-type="fig"}), with two facilities citing serious staffing problem/staffing turnover as reasons. Willing PIs were found at another 4 of the 18 facilities but their research offices declined for two of them, and another two never completed the IRB approval process.

Clinic participation
--------------------

There were 219 clinics affiliated with the 48 participating facilities, of which 168 (77%) participated (Table [2](#T2){ref-type="table"}). As with facilities, most clinics were located in urban areas, with relatively few in the west. The median clinic size (number of clinicians) was 3 (range 1 to 15). Larger clinics and clinics located in urban areas were more likely to participate than their counterparts; clinic participation did not differ by US region.

###### 

Distribution of community-based outpatient clinics and associated clinicians among the 48 participating facilities: the VA MI-Plus study

                                       Clinics   Clinicians                                 
  ------------------------------------ --------- ------------ ------------- ------- ------- ------------
                                       **N**     **N**        **%**         **N**   **N**   **%**
  ALL                                  219       168          76.7%         957     401     41.9%
  [Located in an urban area]{.ul}^a^                                                        
   Yes                                 171       139          81.3%         828     350     42.3%
   No                                  42        26           61.9%         100     44      44.0%
                                                              *p = .007*                    *p = .7*
  [Geographic region]{.ul}                                                                  
   New England/Mid-Atlantic            62        48           77.4%         199     98      49.2%
   Midwest                             70        55           78.6%         273     117     42.9%
   South                               63        48           76.2%         373     145     38.9%
   West                                18        14           77.8%         83      34      41.0%
  Puerto Rico & Virgin Islands         6         3            50.0%         29      7       24.1%
                                                              *p = .6*                      *p = .046*
  [Number of clinicians]{.ul}                                                               
   1                                   38        18           47.4%         39      17      43.6%
   2-3                                 93        71           76.3%         227     107     47.1%
   ≥ 4                                 88        79           89.8%         691     277     40.1%
                                                              *p \< .001*                   *p = .2*

^a^Does not include the six clinics and 29 clinicians from Puerto Rico & the Virgin Islands.

Clinician participation
-----------------------

There were 957 clinicians affiliated with the 219 clinics, of whom 401 (42%) participated (Table [2](#T2){ref-type="table"}). In contrast to clinic participation rates, clinician participation rates did not differ by rural-urban locale or clinic size. As with clinics, clinician participation rates did not differ by geographic region within the continental United States.

Facility recruitment time
-------------------------

Excluding the coordinating center, the facilities were recruited over a 15-month period. Between April 2004 and November 2004, 16 facilities (25% of 65 eligible) were recruited, and between December 2004 and July 2005, 31 facilities were recruited (63% of 49 remaining eligible) (Figure [4](#F4){ref-type="fig"}). The median time from initial facility contact to clinic enrollment was 222 days. This interval decreased by over a third, from a median of 323 to 195 days (*p*\< .001), from the first to second recruitment phase (Figure [5](#F5){ref-type="fig"}). This was largely due to a decrease in facility approval time (255 to 94 days; *p*\< .001), which remained the largest component of recruitment time. In all but three facilities, approval by the R&D committee was required before submission for IRB approval. This initial approval constituted 80% (93 of 116 days) of overall median facility approval time, a percent similar for both phases of the study. Initial contact time (*i.e*., time to identification of local PI) did not differ by facility size overall (*r*= .01) or in either phase. Facility approval time was associated with facility size in the first phase (*r*= .68) but not the second phase (*r*= -.01). As expected, clinic size was inversely (*r*= -.51) associated with time from facility launch date to clinic enrollment (participation); namely, clinics with more clinicians had a clinician log on sooner than did clinics with fewer clinicians, and this association was present in both recruitment phases of the study.

![**Cumulative enrollment by month: the VA MI-Plus study**.](1748-5908-6-105-4){#F4}

![**Median number of days for component intervals from initial facility contact to first clinic enrollment: the VA MI-Plus study**.](1748-5908-6-105-5){#F5}

Clinic/clinician recruitment time
---------------------------------

Over half (n = 90; 53%) of the clinics enrolled within one week of facility launch and most (n = 146; 87%) enrolled within four weeks. Six weeks after facility launch, only 7% of clinics had not enrolled. This pattern was the same for both recruitment phases. The longest time period to enroll a clinic was 10 weeks (n = 3 clinics). Regarding time to last new clinician logging on within a clinic, 25% of clinics had the last new clinician participate by four weeks, 50% by 7.5 weeks, and 75% by 28 weeks. One clinic had a clinician who first logged on 80 weeks after initial invitation. Although we did not formally gather information on clinician refusal, which was passive, qualitatively, most clinicians who did not enroll and were reached by telephone cited lack of time and interest as reason for not participating.

Discussion
==========

The possibility of obtaining a large, nationally representative sample of primary care clinicians (physicians, physician\'s assistants, and nurse practitioners) makes the VHA health system an enticing setting to conduct implementation and outcomes research. With careful planning, a systematic yet flexible approach, and a multidisciplinary staff, it is possible to recruit a nationwide sample of primary care clinicians employed in the VHA\'s community-based outpatient clinics. Over approximately two years, we were able to recruit 401 clinicians representing 168 clinics and 48 facilities in 26 states and Puerto Rico and the Virgin Islands. These groups accounted for 73% of all eligible facilities, over 75% of their associated clinics, and 42% of their clinicians.

Most GRTs do not report a response rate as they have a target number of \"groups\" or practices to recruit for the purposes of statistical power \[[@B15]\] and do not identify, or at least report, a sampling denominator. Our facility and clinic response rates were much higher than the 27% of nursing homes in a GRT study of osteoporosis fracture prevention \[[@B16]\] or the 33% of practices in a managed-care organization\'s study to increase chlamydia screening \[[@B5]\]. Our response rate is similar to non-GRT studies where the purpose was to obtain a population-based nationwide sample. For example, the National Institutes of Health-funded Coronary Artery Risk Development in Young Adults (CARDIA) study has been following an initial cohort of 5,115 community-dwelling healthy young adults first recruited in 1985 for nearly 25 years. The initial 1985 recruitment for CARDIA resulted in a 55% response rate \[[@B17]\]. CARDIA has significantly contributed to our scientific knoweldge, having resulted in over 400 peer-reviewed publications. More recently, the National Institues of Health-funded Cancer Outcomes Research Consortium (CanCORS) was established in 2001 to obtain a representative, population-based sample to study the processes and outcomes of patients with newly diagnosed lung or colorectal cancer \[[@B18]\]. The approximately 10,000 cancer patients recruited with a population-based approach represent about 50% of the underlying target population. As the recruitment methodologies of GRTs become more refined, their findings will be highly generalizable.

Recruiting for GRTs and for RCTs can be viewed under similar theoretical perspectives, including Choo\'s general model of information use identifying major elements that influence information-seeking behavior \[[@B19]\] and the work of Christensen and Armstrong involving diffusion of innovation \[[@B20]\], which includes \"disruptive\" effects. In the VA MI-Plus study, recruitment involved two groups of clinicians: (1) physicians to identify a local PI and (2) clinicians to log on and participate in the intervention. These clinician groups may have different elements that influence their participation. Local PIs had to complete necessary IRB training and submit applications through R&D and IRB committees for study approval at their facility. Even with the parent site (Birmingham) preparing necessary packages in the second phase, obtaining these approvals could be quite time consuming. There was no direct compensation to these individuals. Reasons to participate, as cited by another GRT \[[@B21]\], may include the desire to improve their clinical practice or an interest in contributing to medical knowledge in general, but these benefits must exceed any perceived disruptive effects. In comparison, at the clinic level, a clinician simply had to log on to enroll and thus be classified as participating.

In comparing phase 1 and phase 2 recruiting, we found, as have others \[[@B21],[@B22]\], that physician-to-physician recruiting gave a much greater yield and that prior personal contacts did not have a substantial effect. We also learned that recruitment strategies needed to change over time in order to achieve recruitment targets. Similarly, Ellis *et al*. \[[@B21]\] used 10 different nonrandomized strategies over 11 months to recruit sufficient practices in the GLAD HEART study, a total of 61 practices, all within one US state. In a review of recruitment rates and strategies across studies conducted in one medical center, Johnston *et al*. \[[@B23]\] found considerable variation in recruitment rates despite similar strategies and staffing. Number of recruited practices ranged from 30 to 137; most required over nine months to recruit and most had not planned for the time needed. They found personal connections helpful and have suggested that these personal connections can be developed during the recruiting process. We also found that buy-in from participants (the use of local PIs to champion the study) and a flexible recruitment strategy enhanced recruitment, findings consistent with those of Johnston et al. \[[@B23]\]

Minimization of possible disruptive effects for the clinician may have facilitated recruitment in our study. First, VHA\'s use of EHRs made it possible to extract patient records without interfering with office flow. Also, randomization and analysis was at the clinic level, thus low-performing individual clinicians were not at risk of being identified. Similarly, the use of EHRs and clinics as the randomization unit enabled the recruitment of 20 practices in 14 states for a multimethod GRT \[[@B24]\]. The Ornstein study relied on academic detailing and site visits, components that may be disruptive from the theoretical perspective and expensive or impractical for a nationwide study. Interestingly, the parallel MI-Plus study involving primary care clinicians in Alabama and Mississippi \[[@B25],[@B10],[@B8]\] had a much lower participation rate (13%) for clinicians \[[@B25]\], perhaps because these clinicians lacked EHRs and viewed manual chart abstraction as disruptive to their practices.

Between the first and second phases of our recruitment, the amount of time required to obtain facility approval of the study protocol decreased from a median of 255 days to 94 days. This 63% reduction was primarily attributed to the addition of an experienced IRB staff member at the Study Coordinating Center that allowed for the implementation of a more systematic and structured approach to IRB management. The complexity and sheer volume of work needed to coordinate IRB approval for 48 participating facilities cannot be overstated. The majority of facilities required R&D approval prior to IRB submission, and obtaining R&D approval constituted the bulk of the facility approval time, with IRB approval requiring only an additional two to four weeks. This may be misleading in that many R&D committees wanted \"the essence of the IRB packet\" to review, thus, an IRB specialist is invaluable in facilitating R&D approval as well.

Establishment of the recently implemented central IRB in the VHA (an IRB approved by a central office to cover all participating facilities in a multisite study) should enhance the efficiency, cost, and attractiveness of conducting nationwide GRTs within the VHA. Use of single-study IRB cooperative agreements in the (beta)-Carotene and Retinol Efficacy Trial (CARET) in a university setting reduced the average time to complete IRB approval from over six months to one month for each of many substudies \[[@B26]\]. Even with a central IRB, we anticipate, as have others \[[@B27]-[@B29]\], that a dedicated research assistant or IRB specialist is advised in the planning of any large GRT within or external to the VHA. In 2005, with an established protocol and experienced staff, it took approximately six months from initial contact at a facility to enroll an associated clinic; half of this time (three months) was for facility approval, which perhaps can be reduced to one month with the central IRB recently implemented by the VHA. One challenge that will remain, even with a central IRB, is getting PIs to do requisite training in research practices (*e.g*., good clinical practices, privacy, and security training) needed for IRB approval. This required substantial effort from our study staff, primarily that of the IRB specialist. In an era of ever-increasing regulatory oversight, we believe that this will persist as a substantial task that should be planned for when designing studies and budgeting personnel. A database of and for VHA researchers to register and complete the approval and training necessary to do VHA research should facilitate the recruitment process.

Our conclusions regarding the importance of a functional, truly interdependent relationship between the study PI and the clinical research coordinator echo those of other teams \[[@B30]\]. The success of our study would not have been possible without a close collaboration between these two members of the research team. Evaluating the value-added contribution of such a position should be an important future consideration.

Our experience suggests that using a recruitment approach that seems counterintuitive might be warranted. Our initial efforts to recruit local PIs focused on high-yield targets (*i.e*., personal contacts), largely due to initial anxiety on the part of the recruitment team of cold calling. While recruiting based on familiarity might have made us feel better, the cold peer-to-peer calling successfully recruited many local PIs and proved less difficult and more efficient than anticipated. We might have saved time and improved study efficiency by expending more energy on cold calling local PIs early and getting the recruitment process started and saving the \"easy\" recruits for later. Anecdotally, cold calling individual clinicians to log on was not nearly as successful a recruitment tool as cold calling for local PIs. This observation may be a result of being able to offer the facility of local PIs a site distribution of funds (\$2,500) to cover costs of participating, while we could not offer clinicians any similar distribution of funds for participation in the study owing to VHA policy.

Conclusions
===========

We found that having dedicated research team members, physician investigators, and an IRB specialist actively involved in the recruitment process and using a standardized recruitment protocol greatly increased the ability and efficiency of facility recruitment. These specialized personnel, however, appeared to have very little effect on recruiting clinics and clinicians. We believe that our study demonstrates the ability to do implementation research with a level of generalizability comparable to that of major epidemiologic studies. As group-randomized implementation trials become more common, large healthcare systems, such as the VHA, will provide us with the opportunity to refine our methods and become key \"laboratories\" for the development of implementation science.
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